FIELD: chemical and pharmaceutical industry and medicine.
SUBSTANCE: set of inventions relates to the chemical and pharmaceutical industry and to medicine. A liquid dosage form for oral administration having an anti-inflammatory and/or antiviral effect contains 2-(imidazol-4-yl)ethanamide of pentandium-1.5 acid or a pharmaceutically acceptable salt thereof, 1-[2-(1H-imidazol-4-yl)ethyl]piperidine-2,6-dione pharmaceutically acceptable salt thereof and N,N'-bis-[2-(1N-imidazol-4-yl)ethyl]pentandiamide or pharmaceutically acceptable salt thereof in effective quantities and pharmaceutically acceptable auxiliaries with the pH of the liquid dosage form form being 3 to 8. A method for treating and/or preventing diseases and conditions in which the subject requires the oral administration of an anti-inflammatory and/or antiviral dosage form is also disclosed and its use for treating and/or preventing specified diseases and conditions.
EFFECT: set of inventions provides liquid dosage forms for shared use of said compounds.
16 cl, 33 tbl, 6 ex
